3.2.1. An Attempt at the Synthesis of 4-Aryl-1-phenyl-3-methyl-4,9-dihydro-1H-pyrazolo[3,4-b]quinolines via Three Component Reaction According to Hegde and Shetty Protocol
Procedure a) 865 mg (5 mmol) of 2-phenyl-5-methyl-2,4-dihydro-3H-pyrazol-3-one, 600 mg (5 mmol) p-tolualdehyde, 450 mg (5 mmol) mmol) aniline, 75 mg (20 mol%) L-proline and 10 cm3 ethanol were introduced into a round bottom flask (25 cm3) and placed in a heating block and boiled for 5 hrs under reflux condenser. After the end of heating, the reaction mixture was left for 24 hours in the refrigerator and the separated crystalline precipitate was filtered off. The filtrate was evaporated, the resulting oil was dissolved in chloroform and dried with anhydrous MgSO4. The chloroform was evaporated and the oil obtained was dissolved in petroleum ether (40/60) and chromatographed on a silica gel column. The solution was evaporated and the light yellow oil was left in the refrigerator to solidify.
Procedure b): 5 mmoles of substrates without L-proline were used in the reaction.
4,4’-(4-Methylphenylmethylene)-bis-(3-methyl-1-phenylpyrazol-5-ol) 14a
Procedure a: Colourless crystals, 820 mg, yield 72%, mp. 204-5 °C. Lit. 203-205 °C [
32].
Procedure b: Colourless crystals, 880 mg, yield 78%, mp. 204-5 °C.
1H NMR (400 MHz, DMSO-d6,) δ, ppm (J, Hz): 7.67 (d, J = 7.7 Hz, 4H), 7.40 (t, J = 7.9 Hz, 4H), 7.20 (t, J = 7.3 Hz, 2H), 7.10 (d, J = 8.1 Hz, 2H), 7.04 (d, J = 8.1 Hz, 2H), 4.87 (s, 1H); 2.27 (s, 6H), 2.21 (s, 3H). 13C NMR (101 MHz, DMSO-d6) δ, ppm: 146.8, 139.7, 135.3, 129.5, 129.2, 127.6, 126.1, 121.0, 33.3, 21.1, 12.1.
4-Methyl-N-[(1E)-phenylmethylidene]aniline 15a
Pale yellow crystalline mass, 173 mg, yield 18%, mp. 40-42 °C. Lit. 40-41°C [
24]. TLC testing (toluene:petroleum ether 40/60 ratio 1:1) showed the sample to have identical R
f values to the original Schiff base synthesized from aniline and
p-tolualdehyde .
4,4’-(4-Chlorophenylmethylene)-bis-(3-methyl-1-phenylpyrazol-5-ol) 14b
Procedure a: Colourless crystals, 878 mg, 74 %, mp. 205-6 °C. Lit. 206-8 °C [
33]
Procedure b: Colourless crystals, 950 mg, 80 %, mp. 205-6 °C.
1H NMR(400 MHz, CDCl3) δ, ppm (J, Hz): 13.90 (s, 1H), 7.71 (d, J = 7.6 Hz, 4H), 7.45 (t, J = 8.0 Hz, 4H), 7.34 (d, J = 8.6 Hz, 2H), 7.30 – 7.21 (m, 4H), 4.97 (s, 1H), 2.33 (s, 6H). 13C NMR(100 MHz, CDCl3) δ, ppm (J, Hz): 146.68, 141.63, 131.01, 129.59, 129.42, 129.38, 128.47, 121.02, 33.02, 12.06.
4,4’-(4-Fluorophenylmethylene)-bis-(3-methyl-1-phenylpyrazol-5-ol) 14c
Procedure a: Colourless crystals, 900mg, 79%, mp. 168-9 °C. Lit. 180-1 °C [
33].
Procedure b: Colourless crystals, 980 mg, 86%, mp. 167-8 °C.
1H NMR (400 MHz, DMSO) δ, ppm (J, Hz): 13.95 (s, 1H), 7.72 (d, J = 7.7 Hz, 4H), 7.45 (t, J = 7.9 Hz, 4H), 7.31-7.23 (m, , 4H), 7.11 (t, J = 8.9 Hz, 4H), 4.97 (s, 1H), 2.33 (s, 6H).
4,4’-(4-Methoxyphenylmethylene)-bis-(3-methyl-1-phenylpyrazol-5-ol) 14d
Procedure a: Colourless crystals, 230 mg ( 2 mmol scale), yield 49%, mp. 167-169°C. Lit. 165-167 °C [
33].
1HNMR (400 MHz, DMSO-d6) δ, ppm (J, Hz): 7.67 (d, J = 7,9 Hz, 4H), 7.40 (t, J = 7,6 Hz, 4H), 7.20 (t, J = 7,0 Hz, 2H), 7.12 (d, J = 8,3 Hz, 2H), 6.80 (d, J = 8,4 Hz, 2H), 4.86 (s, 1H), 4.86 (s, 3H), 2.27 (s, 6H). 13C NMR (100 MHz, DMSO-d6) δ, ppm (J, Hz): 158.04, 146.69, 134.45, 129.28, 128.70, 126.03, 121.03, 114.03, 55.52, 32.87, 11.73.
4,4’-(2,4-Dichlorophenylmethylene)-bis-(3-methyl-1-phenylpyrazol-5-ol) 14e
Procedure a: Colourless crystals, 1100 mg, yield 86%, p. 234-5 °C. Lit. 228-230 °C [
31]
Procedure b: Colourless crystals, 1000 mg, yield 79%, p. 233-5 °C.
1H NMR(400 MHz, DMSO-d6,) δ, ppm (J, Hz): 13.83 (s, 1H), 7.76 (d, J = 8.5 Hz, 1H), 7.70 (d, J = 7.7 Hz, 4H), 7.55 (d, J = 2.2 Hz, 1H, 7.43 (dt, J = 8.9, 5.0 Hz, 5H 7.25 (t, J = 7.4 Hz, 2H), 5.10 (s, 1H), 2.29 (s, 6H). 13C NMR(100 MHz, DMSO-d6,) δ, ppm: 146.47, 138.93, 133.36, 132.12, 131.90, 129.39, 129.31, 127.45, 126.15, 121.07, 31.84, 12.28.
4,4’-(4-Nitrophenylmethylene)-bis-(3-methyl-1-phenylpyrazol-5-ol) 14f
Procedure a: Colourless crystals, 850 mg, yield 71%, mp. 234-5 °C. Lit. 228-230 °C [
31]
Procedure b: Colourless crystals, 900 mg, 75%, mp. 233-4 °C.
1H NMR(400 MHz, DMSO-d6,) δ, ppm (J, Hz): 13.87 (s, 1H), 8.18 (d, J = 8.9 Hz, 2H), 7.71 (d, J = 7.6 Hz, 4H), 7.53 (d, J = 8.4 Hz, 2H), 7.45 (t, J = 8.0 Hz, 4H), 7.26 (t, J = 7.4 Hz, 2H), 5.14 (s, 1H), 2.36 (s, 6H).13C NMR(101 MHz, DMSO-d6,) δ, ppm : 150.78, 146.75, 146.38, 129.40, 129.08, 126.20, 123.80, 121.07, 33.64, 12.05.
4,4’-(2-Thienylmethylene)-bis-(3-methyl-1-phenylpyrazol-5-ol) 14g
Procedure a: Colourless crystals, 140 mg ( 2 mmol scale), 33%, mp. 187-189 °C. Lit. 189-190 °C [
34].
Procedure b: Colourless crystals, 500mg ( 5 mmol scale), 45%, mp. 187-188 °C.
1H NMR (400 MHz, DMSO-d6,) δ, ppm (J, Hz): 7.67 (d, J = 8,6 Hz, 1,0 Hz, 4H), 7,41 (t, J = 8.0 Hz, 4H), 7.27-7.18 (m, 3H), 6,87 (dd, J = 5.1 Hz, 3.5Hz, 1H), 6.73-6.69 (m, 1H), 5.09 (s, 1H), 2.28 (s, 6H). 13C NMR (101MHz, DMSO-d6) δ, ppm: 148.06, 146.34, 129.48, 127.30, 126.22, 124.69, 124.59, 29.98, 12.05.
4,4’-(4-Hydroxyphenylmethylene)-bis-(3-methyl-1-phenylpyrazol-5-ol) 14h
The reaction was carried out on a 5 mmol scale using 30 ml of ethanol as a solvent.
Procedure a: Yellow crystals, 890 mg, yield 78%, mp. 158-160 °C. Lit. 153-155 °C [
27].
Procedure b: Yellow crystals, 930 mg, yield 82%, mp. 158-159 °C.
1H NMR (400 MHz, DMSO-d6,) δ, ppm (J, Hz): 13.94 (s, 1H), 9.18 (s, 1H), 7.72 (d, J = 7.8 Hz, 4H), 7.45 (t, J = 7.9 Hz, 4H), 7.25 (t, J = 7.3 Hz, 2H), 7.06 (d, J = 8.5 Hz, 2H), 6.68 (d, J = 8.6 Hz, 2H), 4.86 (s, 1H), 2.31 (s, 6H). 13C NMR (101MHz, DMSO-d6) δ, ppm: 155.96, 146.64, 132.73, 129.36, 128.55, 125.96, 120.95, 115.31, 32.84, 12.09.
4,4’-(3,4-Dimethoxyphenylmethylene)-bis-(3-methyl-1-phenylpyrazol-5-ol) 14i
The reaction was carried out on a 5 mmol scale using 30 ml of ethanol as a solvent.
Procedure a: Colourless crystals, 1050 mg, 85%, mp. 208-9 °C. Lit. 194-196 °C [
27].
Procedure b: Colourless crystals, 1100 mg, 89%, mp. 207-9 °C.
1H NMR (400 MHz, DMSO-d6,) δ, ppm (J, Hz): 14.02 (s, 1H), 12.39 (s, 1H), 7.71 (d, J = 7.7 Hz, 4H), 7.45 (t, J = 7.9 Hz, 4H), 7.25 (t, J = 7.3 Hz, 2H), 6.85 (ddd, J = 17.9, 8.6, 1.6 Hz, 3H), 4.89 (s, 1H), 3.71 (s, 1H), 3.66 (s, 1H), 2.32 (s, 6H). 13C NMR (101MHz, DMSO-d6) δ, ppm: 148.86, 147.70, 146.63, 135.42, 129.38, 121.05, 119.76, 112.23, 112.09, 56.02, 55.96, 33.38, 12.13.
4,4’-(2-Furylmethylene)-bis-(3-methyl-1-phenylpyrazol-5-ol) 14j
The compound could not be isolated from the post-reaction mixture, but its presence was detected using TLC and compared with the original substance obtained in the reaction of pyrazolone 6b and 2-furylaldehyde.
(4E)-4-[(4-hydroxyphenyl)methylidene]-5-methyl-2-phenyl-2,4-dihydro-3H-pyrazol-3-one 16a
Procedure a: Orange crystals, 970 mg, yield 69%, mp. 239-240 °C. Lit. 238 °C [
35]
1H NMR (600 MHz, DMSO) δ, ppm (J, Hz): 10.84 (s, 1H), 8.64 (d, J = 8.8 Hz, 2H), 7.93 (d, J = 7.6 Hz, 2H), 7.70 (s, 1H), 7.45 – 7.40 (m, 2H), 7.18 (t, J = 7.4 Hz, 1H), 6.95 (d, J = 8.9 Hz, 2H), 2.32 (s, 3H).
(4E)-4-[(3,4-dimethoxyphenyl)methylidene]-5-methyl-2-phenyl-2,4-dihydro-3H-pyrazol-3-one 16b
Procedure a: Orange crystals, 1230 mg, yield 76%, mp. 165-6 °C.
1H NMR (600 MHz, CDCl3) δ, ppm (J, Hz): 9.02 (s, 1H), 7.97 (d, J = 7.6 Hz, 2H), 7.71 (dd, J = 8.5, 2.0 Hz, 1H), 7.45 – 7.41 (m, 2H), 7.32 (s, 1H), 7.20 (t, J = 7.4 Hz, 1H), 6.96 (d, J = 8.4 Hz, 1H), 4.06 (s, 3H), 3.99 (s, 3H), 2.35 (s, 3H).
Calcd for: C19H18N2O3 C 70.79; H 5.63; N 8.69 Found 70.63; H 5.46; N 8.48.
3.2.3. Synthesis of 4-Aryl-4,9H-dihydro-3-methyl-1-phenyl-1H-pyrazolo[3,4-b]quinolines by Cyclisation of 3-Methyl-N,1-diphenyl-1H-pyrazol-5-amine 20 with Aldehydes 2
3-Oxo-N-phenylbutanethioamide 18
The compound was prepared according to literature procedure [
36].
3-Methyl-N,1-diphenyl-1H-pyrazol-5-amine 20
In a round bottom flask (100 cm
3) were placed 6.7 g (0.035 mol) of 3-oxo-
N-phenylbutanethiamide, 4 g (0.037 mol) of phenylhydrazine and 20 cm
3 of glacial acetic acid. The mixture was refluxed for 12 hours until the evolution of hydrogen sulfide ceased. The acetic acid was evaporated and the resulting oil was treated with 10% NaHCO
3. The mixture was extracted with methylene chloride. The organic layer was dried with anhydrous MgSO
4. After removal of the sulfate, the solution was passed through a layer of alumina, evaporated and crystallized from toluene and petroleum ether with small amount of charcoal to decolorize final product. 6.74 g (77%) of light yellow crystals were obtained. M.p. 119-120 °C. Lit. 120 °C, 122-3 °C [
37,
38].
A glass vial (10 mL) equipped with magnetic stirring bar was charged with anhydrous zinc chloride (200mg, 1.5 mmol), p-tolualdehyde 2a ( 180mg, 1.5 mmol) and 20 (380 mg, 1.5 mmol). The vial was closed with with an air condenser and inserted into aluminum heating block and heated at 125 °C for 6 hours with stirring. After cooling the melt was digested with ethanol, sonicated and filtered of to remove pyrazolo[3,4-b]quinoline 7a. A filtrate was evaporated and the resulted oil was dissolved in toluene and chromatographed on column packed with silica gel (Merck 60, 70-230 mesh) using toluene – ethyl acetate mixture as eluent (toluene: AcOEt/ 3:0.1 →3:0.4) to separate 13a from 22a. The experiment was performed in two-fold way – in an open vial and with a closed vial.
4-(4-Methylphenyl)-3-methyl-1-phenyl-1H-pyrazolo[3,4-b]quinoline 7a
Yellow crystals, 150 mg, 26.7% (an open vial), 35 mg, 6.3% (a closed vial), mp. 208-210 °C. Lit. 206-207°C [
11].
1H NMR(400 MHz, CDCl3) δ, ppm (J, Hz): 8.55 (d, J = 7.7 Hz, 2H), 8.23 (d, J = 8.1 Hz, 1H), 7.77 (t, J = 7.7 Hz, 4H), 7.59 (dd, J = 8.4, 7.6 Hz, 4H), 7.40 (dt, J = 13.7, 8.1 Hz, 5H), 7.31 (t, J = 7.4 Hz, 1H), 2.56 (s, 3H), 2.20 (s, 3H). 13C NMR (101 MHz, CDCl3) δ, ppm: δ 150.18, 148.49, 144.76, 143.97, 140.02, 138.62, 131.93, 130.25, 129.64, 129.03, 128.94, 127.06, 124.88, 123.81, 120.33, 116.46, 21.46, 15.07.
4-(4-Methylphenyl)-4,9-dihydro-3-methyl-1-phenyl-1H-pyrazolo[3,4-b]quinoline 13a
Colourless crystals, 67 mg, 11.6 % (open vial), 174 mg, 30,1% (closed vial), m.p. 178-180 °C.
1H NMR(400 MHz, CDCl3) δ, ppm (J, Hz): 7.60-7.54(m, 2H); 7.54-7.47(m, 2H); 7.34(t, J = 7.3 MHz, 1H), 7,15(d, J = 8.1Hz, 2H); 6.86-6.79(m, 1H); 6.74(dd, J = 8.4; 0.9Hz, 1H); 6.29 (s, 1H, N-H), 5.29(s, 1H), 2.31(s, 3H); 1.95(s, 3H). 13C NMR(100 MHz, CDCl3) δ, ppm : 147.72; 144.35; 138.58; 138.55, 137.20; 135.95; 131.32; 129.90, 129.33; 128.23; 127.25; 126.98; 125.00; 122.79; 122.13; 115.90; 100.77; 42.06, 21.15, 12.66.
Calculated for C24H21N3 ESI (M + H+) = 352,1808. Measured: ESI(M+H+) = 352,20.
4,4’-(4-Metylphenylmethylene)-bis-[3-methyl-N,1-diphenyl-1H-pyrazol-5-amine] 22a
Colourless crystals, 218 mg (closed vial), 45 %, mp. 198-99 °C
1H NMR(400 MHz, CDCl3) δ, ppm (J, Hz): 7,45(d, J = 7.9Hz, 4H); 7.30-7.21(m, 5H); 7.16(t, J = 7.4Hz, 2H); 7.03-6.82(m, 7H); 6.66(t, J = 7.3Hz, 2H); 6.26(d, J = 7.8Hz, 4H); 5.18(s, 1H); 4.58(s, 2H), 2,24(s, 3H); 1,97(s, 6H). 13C NMR(101 MHz, CDCl3) δ, ppm: 148.33; 144.71; 139.07; 137.37; 136.09; 129.09; 128.89; 128.18; 126.68; 122.92; 119.62; 115.07; 113.91; 36.34 (CH-methylene); 21.06 (C6H4CH3); 13.94 (3-CH3).
Cald. for C40H36N6 : ESI (M+H+) = 601,3074. Measured : ESI (M+H+) = 601,35.
4-(p-Chlorophenyl)-1-phenyl-3-methyl-1H-pyrazolo[3,4-b]quinoline 7b
Yellow crystals, 32 mg, 5.4%, mp. 230-231°C. The sample was identified with original one prepared according to literature procedure [
39].
4-(p-Chlorophenyl)-4,9-dihydro-1-phenyl-3-methyl-1H-pyrazolo[3,4-b]quinoline 13b
Pale yellow powder, 53 mg, 8.9%, m.p. 129-130 °C.
1H NMR(400 MHz, CDCl3) δ, ppm (J, Hz): 7.62-7.57(m, 2H); 7.57-7.49(m, 2H); 7.41-7.34(m, 1H); 7.32-7.26(m, 1H); 7.26-7.20(m, 1H); 7.15-7.07(m, 1H); 7.03(t, J = 7.5Hz, 1H); 6.91-6.83(m, 1H); 6.78(dd, J = 8.0Hz; 0.8Hz, 1H), 6.41(s, 1H, N-H); 5,34(s, 1H, C-H); 1,98(s, 3H, 3-CH3). 13C NMR(100 MHz, CDCl3) δ, ppm:147.42; 145.72; 138.52; 137.10; 132.16; 131.14; 129.82; 129.52; 128.48; 127.40; 126.98; 124.15; 122.69; 122.08, 115.89; 100.05; 41.11; 12.59.
Calcd for C23H18ClN3 C 74.29; H 4.88; N 11.30. Found C 74.03; H 4.56; N 11.18.
4,4’-(4-Chlorophenylmethylene)-bis-[3-methyl-N,1-diphenyl-1H-pyrazol-5-amine)] 22b
White powder, 222 mg, 44.5%, mp. 202-3 °C.
1H NMR(400 MHz, CDCl3) δ, ppm: 7.51-7.43(m, 4H); 7.31(t, J = 7.8Hz, 4H); 7.21(t, J = 7.4Hz, 2H); 7.10(d, J = 8.5Hz, 2H); 7.02(dd, J = 16.5Hz, 8.7Hz, 6H); 6,72(t, J = 7.4Hz, 2H); 6,29(d, J = 7.7Hz, 4H); 5,20(s, 1H); 4,59(s, 2H); 2,02(s, 6H). 13C NMR(100 MHz, CDCl3) δ, ppm :148.00; 144.58; 139.04; 138.83; 137.26; 132.21; 129.37; 129.07; 129.01; 128.55; 126.78; 122.92; 119.69; 114.66; 113.74; 36.21; 13.91.
Calcd for C39H33ClN6 C 75.41; H 5.35; N 13.53 Found C 75.32; H 5.23; N 13.48.
4-(2,4-Dichlorophenyl)-1-phenyl-3-methyl-1H-pyrazolo[3,4-b]quinoline 7e
In this procedure 300 mg of 20 and 210 mg of 2,4-dichlorobenzaldehyde were used for reaction.
Yellow crystals, 24 mg (closed vial), 4,9 %, m.p. 158-9 °C.
1H NMR(400 MHz, CDCl3) δ, ppm (J, Hz): 8,54(dd, J = 8.7; 1,1Hz, 2H); 8.26(d, J = 8.3Hz, 1H); 7.83-7.77(m, 1H); 7.72(d, J = 2.0 Hz, 1H); 7.62-7.50(m, 2H); 7.46-7.40(m, 1H), 7.38(d, J = 8.2Hz, 1H); 7.35-7.29(m, 1H); 2.22(s, 3H, 3-Me).13C NMR(100 MHz, CDCl3) δ, ppm: 150.13; 148.53; 143.17; 139.85; 139.55; 135.85; 134.73; 132.69; 132.14; 130.45; 129.73; 129.28; 129.06; 127.24; 126.00; 125.09; 124.55; 122.92; 120.33; 116.31; 14.17.
Calcd for C23H15Cl2N3 C 68,33; H 3.74; N 10.39. Found C 68.14; H 3.45; N 10.28.
4-(p-2,4-Dichlorophenyl)-4,9-dihydro-1-phenyl-3-methyl-1H-pyrazolo[3,4-b]quinoline 13e
Pale yellow crystals, 128 mg, 27%, m.p. 220-1°C.
1H NMR(400 MHz, CDCl3) δ, ppm: 7.62-7.57(m, 2H); 7.54(dd, J = 10.5Hz, 5.2Hz, 2H); 7,44(t, J = 1.1Hz, 1H); 7.41-7.35(m, 1H); 7.16(d, J = 1.1Hz, 2H); 7.14-7.09 (m, 1H); 7.08(d, J = 7.7Hz, 1H); 6.90-6.84(m, 1H); 6.78(dd, J = 8.0Hz, 0.8Hz, 1H); 6.42(s, 1H, N-H); 5.99(s, 1H, C-H); 1.97(s, 3H). 13C NMR(100 MHz, CDCl3) δ, ppm: 147.37; 143.43; 138.76; 138.42; 137.10; 132.76; 132.52; 132.43; 130.74; 129.83; 128.88; 128.11; 127.66; 127.03; 123.65; 122.48; 122.24; 115.90; 99.69; 36.85; 11.91.
Calcd for C23H17Cl2N3 C 67,99; H 4,22; N 10,34. C 67.81; H 4.08; N 10.17.
4-(Thienyl-2-ylo)-3-methyl-1-phenyl-1H-pyrazolo[3,4-b]quinoline 7d
Yellow crystals, 95 mg (closed vial), 17%, m.p. 141-2 °C.
1H NMR(400 MHz, CDCl3) δ, ppm (J, Hz): 8,48(dd, J = 8.7Hz, 1.1Hz, 2H); 8.17(d, J = 7.8Hz, 1H); 7,89(d, J = 8.6Hz, 1H); 7.77-7.71(m, 1H); 7.64(dd, J = 5.1Hz, 1.2Hz, 1H); 7.58-7.51(m, 2H); 7.43-7.38(m, 1H); 7.31-7.23(m, 3H), 2,3(s, 3H). 13C NMR(101 MHz, CDCl3) δ, ppm: 153.47; 146.80; 139.27; 139.17; 138.29; 130.89; 129.93; 127.76; 126.99; 126.82; 125.33; 124.10; 123.65; 123.06; 121.50; 117.28; 99.95; 36.85; 1267.
Calcd for: C21H15N3S C 73.87; H 4.43; N 12.31. Found C 73.57; H 4.28; N 12.18.
4-(Thienyl-2-ylo)-4,9-dihydro-3-methyl-1-phenyl-1H-pirazolo[3,4-b]quinoline 13g
Colourless crystals, 150 mg, 29 %, m.p. 274-6 °C.
1H NMR(400 MHz, CDCl3) δ, ppm: 9.02(s, 1H); 7.58-7.46(m, 4H); 7.32(t, J = 7.2Hz, 1H); 7.26(t, J = 7.5 Hz, 1H); 7.12(d, J = 7.6Hz, 1H); 7.04(d, J = 4.1Hz, 2H); 6.98(d, J = 4.1Hz, 1H); 6,88(dd, J = 5.0Hz, 3.5Hz, 1H); 6.83-6.75(m, 1H); 5.67(s, 1H); 1.90(s, 3H). 13C NMR(100 MHz, CDCl3) δ, ppm: 153.47; 146.80; 139.27; 139.17; 138.29; 130.89; 129.93; 127.76; 126.99; 126.82; 125.42; 124.10; 123.65; 123.06; 121.50; 117.28; 99.95; 36.85; 12.67.
Calculated for C21H15N3S: ESI(M+H+) = 344,1216. Measured: ESI(M+H+) = 344,10.